Abstract
“The authors have withdrawn their manuscript because they identified errors in the vitamin D levels and VDR gene polymorphisms section. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.”
Competing Interest Statement
dfgbdfghn
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Vitamin D status in T1D Demographic and clinical details of T1D patients and their family members as control group are furnished in Table 1. The serum 25-(OH) vitamin D level was significantly lower in T1D patients than healthy siblings (p <0.00001) (Figure. 1). Based on vitamin D status, the present study identified that the frequency of VDS was lower in T1D patients than that of healthy siblings (p=0.05). Whereas, VDD was higher in T1D patients than that of healthy siblings (p=0.03). However, VDI exhibited not much deviation (p=0.29) among the groups (Table 1). VDR polymorphisms in trios study Single point TDT analysis identified that VDR-ApaI-A (p=0.006; χ2= 7.3; T:U=15/5) and VDR-BsmI-B (p=0.01; χ2= 6.5; T:U=17/5) alleles were significantly over-transmitted from parents to T1D patients. However, the VDR-FokI-F and VDR-TaqI- T alleles did not show any deviation in allele transmission. Multi-point TDT analysis shown baT haplotype significantly under-transmitted (p=0.04; χ2= 4.1; T:U=5.4/14.4 with 10,000 permutation) from parents to the T1D patients (Table 2). LD analysis showed that TaqI, ApaI and BsmI SNPs of VDR gene are in single haplotype block (Figure 2). The correlation coefficient (D') value was equal to 1 with r2 value more than 0.3 which indicated high LD between SNPs. High LD was observed between three SNPs, TaqI-ApaI (D'=1.0; LOD=14.02; r2=0.45) TaqI-BsmI (D'=0.92; LOD=19.9; r2=0.68) and BsmI-ApaI (D'=1.0; LOD=18.73; r2=0.62) from four selected SNPs. VDR polymorphisms in case-control study Distribution of allele and genotype frequency of VDR gene polymorphisms (FokI, BsmI, ApaI and TaqI) are given in Table 3. The frequency of FokI-FF genotype (OR=1.6639; CI=1.0526 - 2.6302; p=0.03) significantly higher in the T1D patients and FokI-Ff genotype (OR=0.5699; CI=0.3572-0.9092; p=0.02) significantly lower in the T1D patients when compared to healthy controls. However, genotype frequency of BsmI, ApaI and TaqI and the allele of the selected four SNPs were not observed the significant differences between T1D patients and healthy controls. Moreover, the distribution of VDR haplotype frequency did not show significant differences between T1D patients and healthy controls (Data not shown).
